Catalyst Wire Dossier Catalyst Wire Dossier

Qiangke

Etanercept · Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Qiangke, covering 2016-03-08 to 2016-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis [Phase 3]

See pricing